Skip to main content
SpringerLink
Log in

Pathology of Inflammatory Bowel Diseases and Its Mimickers, Immunodeficiency and Vascular Gastrointestinal Lesions, and Drug-Induced Bowel Pathologies

  • Chapter
  • First Online:
Surgical Pathology of the Gastrointestinal System

  • 1815 Accesses

Abstract

This chapter describes important acute and chronic inflammatory lesions of the intestine, along with immunodeficiency diseases and vascular and drug-induced lesions of the bowel. This chapter highlights the epidemiology of these important groups of diseases, their common locations, gross and microscopic pathologies, approach to diagnosis, and differentials to consider before a diagnosis is made. This chapter brings out essential lucid descriptions of these lesions and diagnostic tips for the readers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lakatos P-L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12(38):6102–8.

    PubMed  PubMed Central  Google Scholar 

  2. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104(8):2100–9.

    PubMed  Google Scholar 

  3. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158–65.

    PubMed  Google Scholar 

  4. Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54(5):1099–107.

    PubMed  Google Scholar 

  5. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut. 2003;52(11):1587–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Antia FP. Crohn’s conundrum in Indians. Indian J Gastroenterol. 1986;5(2):79–80.

    CAS  PubMed  Google Scholar 

  7. Pulimood AB. Differentiation of Crohn’s disease from intestinal tuberculosis in India in 2010. World J Gastroenterol. 2011;17(4):433.

    PubMed  PubMed Central  Google Scholar 

  8. Bandyopadhyay S. Crohn’s disease: the Indian perspective. Medicine (Baltimore) [Internet]. 2012 [cited 2015 Feb 15];22. Available from: http://www.apiindia.org/pdf/medicine_update_2012/gastroenterology_01.pdf.

  9. Amarapurkar D-N. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14(5):741.

    PubMed  PubMed Central  Google Scholar 

  10. Ray G. Inflammatory bowel disease in India--changing paradigms. Int J Color Dis. 2011;26(5):635–44.

    Google Scholar 

  11. Pai CG, Khandige GK. Is Crohn’s disease rare in India? Indian J Gastroenterol. 2000;19(1):17–20.

    CAS  PubMed  Google Scholar 

  12. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol. 1993;88(7):989–99.

    CAS  PubMed  Google Scholar 

  13. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.

    CAS  PubMed  Google Scholar 

  14. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140:1704–12.

    CAS  PubMed  Google Scholar 

  15. Bayless TM, Tokayer AZ, Polito JM 2nd, Quaskey SA, Mellits ED, Harris ML. Crohn’s disease: concordance for site and clinical type in affected family members--potential hereditary influences. Gastroenterology. 1996;111:573–9.

    CAS  PubMed  Google Scholar 

  16. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Loddo I, Romano C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front Immunol. 2015;6:551.

    PubMed  PubMed Central  Google Scholar 

  18. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317; Thompson Al, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis. 2011;17:831–48.

    Google Scholar 

  19. Liu JZ, Van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol. 2009;3:513–34.

    CAS  PubMed  Google Scholar 

  21. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.

    CAS  PubMed  Google Scholar 

  22. Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007;133(4):1327–39.

    CAS  PubMed  Google Scholar 

  23. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40(8):955–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–34.

    CAS  PubMed  Google Scholar 

  25. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–78.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104:741–8.

    CAS  PubMed  Google Scholar 

  27. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. Virus-plus-susceptibility gene interaction determines Crohn’s disease gene Atg16L1 phenotypes in intestine. Cell. 2010;141(7):1135–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi PG. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol. 1987;125:445–52.

    CAS  PubMed  Google Scholar 

  29. Harries AD, Jones L, Heatley RV, Rhodes J. Smoking habits and inflammatory bowel disease: effect on nutrition. Br Med J (Clin Res Ed). 1982;284:1161.

    CAS  Google Scholar 

  30. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15(3):382–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol. 2018;53(1):95–106.

    PubMed  Google Scholar 

  32. Miyoshi J, Sofia MA, Pierre JF. The evidence for fungus in Crohn’s disease pathogenesis. Clin J Gastroenterol. 2018;11(6):449–56. https://doi.org/10.1007/s12328-018-0886-9.

    Article  PubMed  Google Scholar 

  33. Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160(3):447–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Aniwan S, Tremaine WJ, Raffals LE, Kane SV, Loftus EV Jr. Antibiotic use and new-onset Inflammatory Bowel disease in Olmsted County, Minnesota: a population-based case-control study. J Crohns Colitis. 2018;12(2):137–44.

    PubMed  Google Scholar 

  35. Wilks J, Beilinson H, Golovkina TV. Dual role of commensal bacteria in viral infections. Immunol Rev. 2013;255(1):222–9.

    PubMed  Google Scholar 

  36. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262–7.

    CAS  PubMed  Google Scholar 

  37. Fabia R, Ar'Rajab A, Johansson ML, Andersson R, Willen R, Jeppsson B, et al. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion. 1993;54:248–55.

    CAS  PubMed  Google Scholar 

  38. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci. 1984;29:1073–9.

    CAS  PubMed  Google Scholar 

  39. Khan IA, Pilli S, Rampal R, Chauhan SK, Tiwari V, Mouli VP, Kedia S, Nayak B, Das P, Makharia GK, Ahuja V. Prevalence and association of Mycobacterium avium subspecies paratuberculosis with disease course in patients with ulcero-constrictive ileocolonic disease. PLoS One. 2016;11(3):e0152063.

    PubMed  PubMed Central  Google Scholar 

  40. Lamps LW, Madhusudhan KT, Havens JM, Greenson JK, Bronner MP, Chiles MC, et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn’s disease. Am J Surg Pathol. 2003;27:220–7.

    PubMed  Google Scholar 

  41. Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw. 2017;17(1):25–40.

    PubMed  PubMed Central  Google Scholar 

  42. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995;101(3):428–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn’s disease. Am J Pathol. 1997;150(3):823–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles CH, Rampton DS, et al. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut. 2009;58(12):1629–36.

    CAS  PubMed  Google Scholar 

  45. Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011;208(6):1127–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005;129(1):50–65.

    CAS  PubMed  Google Scholar 

  47. Magnusson MK, Brynjolfsson SF, Dige A, Uronen-Hansson H, Borjesson LG, Bengtsson JL, et al. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation. Mucosal Immunol. 2016;9(1):171–82.

    CAS  PubMed  Google Scholar 

  48. Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn’s disease of the colon. Gastroenterology. 1987;93:919–24.

    CAS  PubMed  Google Scholar 

  49. McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut. 1990;31:536–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202–10.

    CAS  PubMed  Google Scholar 

  51. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116(2):301–9.

    CAS  PubMed  Google Scholar 

  52. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159(6):2001–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Soderholm JD, Peterson KH, Olaison G, Franzen LE, Westrom B, Magnusson KE, et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn’s disease? Gastroenterology. 1999;117(1):65–72.

    CAS  PubMed  Google Scholar 

  54. Goswami P, Das P, Verma AK, Prakash S, Das TK, Nag TC, Ahuja V, Gupta SD, Makharia GK. Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn’s disease? Virchows Arch. 2014;465(5):521–30.

    CAS  PubMed  Google Scholar 

  55. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem. 2010;285(16):12037–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Hoefkens E, Nys K, John JM, Van Steen K, Arijs I, Van der Goten J, et al. Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress. Autophagy. 2013;9(12):2046–55.

    CAS  PubMed  Google Scholar 

  57. Moum B, Ekbom A, Vatn MH, Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol. 1999;94(6):1564–9.

    CAS  PubMed  Google Scholar 

  58. Robert ME, Skacel M, Ullman T, Bernstein CN, Easley K, Goldblum JR. Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases. Am J Clin Pathol. 2004;122(1):94–9.

    PubMed  Google Scholar 

  59. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Joo M, Odze RD. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol. 2010;34(5):689–96.

    PubMed  Google Scholar 

  61. Swan NC, Geoghegan JG, O’Donoghue DP, Hyland JM, Sheahan K. Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis. Dis Colon Rectum. 1998;41(12):1511–5.

    CAS  PubMed  Google Scholar 

  62. Vanderheyden AD, Mitros FA. Pathologist surgeon interface in idiopathic inflammatory bowel disease. Surg Clin North Am. 2007;87(3):763–85.

    PubMed  Google Scholar 

  63. Washington K, Greenson JK, Montgomery E, Shyr Y, Crissinger KD, Polk DB, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002;26(11):1441–9.

    PubMed  Google Scholar 

  64. Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol. 1999;94(11):3258–62.

    CAS  PubMed  Google Scholar 

  65. Haskell H, Andrews CW, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, et al. Pathologic features and clinical significance of “backwash” ileitis in ulcerative colitis. Am J Surg Pathol. 2005;29(11):1472–81.

    PubMed  Google Scholar 

  66. Mitsuishi T. Correlation between histological findings and endoscopic findings in patients with ulcerative colitis: Basal plasmacytosis is an important finding suggesting active inflammation. JGH Open. 2019;3(2):100–4.

    PubMed  Google Scholar 

  67. Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66(12):1005–26.

    PubMed  Google Scholar 

  68. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol. 1997;50(2):93–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Seldenrijk CA, Morson BC, Meuwissen SG, Schipper NW, Lindeman J, Meijer CJ. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut. 1991;32(12):1514–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, Leader M, et al. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut. 1994;35(7):961–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827–51.

    CAS  PubMed  Google Scholar 

  72. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis. 2008;2(1):1–23.

    CAS  PubMed  Google Scholar 

  73. Surawicz CM, Haggitt RC, Husseman M, McFarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology. 1994;107(3):755–63.

    CAS  PubMed  Google Scholar 

  74. Levine DS, Haggitt RC. Normal histology of the colon. Am J Surg Pathol. 1989;13(11):966–84.

    CAS  PubMed  Google Scholar 

  75. Surawicz CM, Meisel JL, Ylvisaker T, Saunders DR, Rubin CE. Rectal biopsy in the diagnosis of Crohn’s disease: value of multiple biopsies and serial sectioning. Gastroenterology. 1981;80(1):66–71.

    CAS  PubMed  Google Scholar 

  76. Washington K, Greenson JK, Montgomery E, Shyr Y, Crissinger KD, Polk DB, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002;26(11):1441–9.

    PubMed  Google Scholar 

  77. Robert ME, Tang L, Hao LM, Reyes-Mugica M. Patterns of inflammation in mucosal biopsies of ulcerative colitis: perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol. 2004;28(2):183–9.

    CAS  PubMed  Google Scholar 

  78. Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology. 1987;92(2):318–28.

    CAS  PubMed  Google Scholar 

  79. Allison MC, Hamilton-Dutoit SJ, Dhillon AP, Pounder RE. The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med. 1987;65(248):985–95.

    CAS  PubMed  Google Scholar 

  80. Schumacher G, Kollberg B, Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol. 1994;29(4):318–32.

    CAS  PubMed  Google Scholar 

  81. Skinner JM, Whitehead R. The plasma cells in inflammatory disease of the colon: a quantitative study. J Clin Pathol. 1974;27(8):643–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA. Reproducibility of histological assessments of disease activity in UC. Gut. 2015;64(11):1765–73.

    PubMed  Google Scholar 

  83. Pai RK, Jairath V, Casteele NV, Rieder F, Parker CE, Lauwers GY. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2018;88(6):887–98.

    PubMed  Google Scholar 

  84. Stange EF, Travis SPL, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut. 2006;55(Suppl 1):i1–15.

    PubMed  PubMed Central  Google Scholar 

  85. Al-Haddad S, Riddell RH. The role of eosinophils in inflammatory bowel disease. Gut. 2005;54(12):1674–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Park S, Abdi T, Gentry M, Laine L. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2016;111(12):1692–701.

    PubMed  Google Scholar 

  87. Villanacci V, Bassotti G, Langner C. Histological remission in inflammatory bowel disease: where are we, and where are we going? J Crohn's Colitis. 2015;9(5):428.

    Google Scholar 

  88. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756–70.

    PubMed  Google Scholar 

  89. Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Mosli MH, Feagan BG, Zou G, et al. Development and validation of a histological index for UC. Gut. 2017;66:50–8.

    PubMed  Google Scholar 

  92. Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, Diebold MD, Danese S, Reinisch W, Schreiber S, Travis S. Development and validation of the Nancy histological index for UC. Gut. 2017;66(1):43–9.

    PubMed  Google Scholar 

  93. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133(4):1099–105.

    PubMed  Google Scholar 

  94. Lutgens MWMD, van Oijen MGH, van der Heijden GJMG, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–99.

    PubMed  Google Scholar 

  95. Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era. Ther Adv Gastroenterol. 2020;13:1756284820920779.

    CAS  Google Scholar 

  96. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–45.

    PubMed  Google Scholar 

  97. Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol. 1994;89:119–22.

    CAS  PubMed  Google Scholar 

  98. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501.e26.

    PubMed  Google Scholar 

  99. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–8.

    Google Scholar 

  100. Bressenot A, Cahn V, Danese S. Laurent Peyrin-Biroulet Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol. 2014;20(12):3164–72.

    PubMed  PubMed Central  Google Scholar 

  101. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544–60.

    PubMed  Google Scholar 

  102. DeRoche TC, Xiao SY, Liu X. Histological evaluation in ulcerative colitis. Gastroenterol Rep (Oxf). 2014;2(3):178–92.

    Google Scholar 

  103. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut. 1997;41:522–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–97.

    PubMed  PubMed Central  Google Scholar 

  105. Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(4):269–76.

    PubMed  PubMed Central  Google Scholar 

  106. Desai D, Shah S, Deshmukh A, et al. Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol. 2015;21(12):3644–9.

    PubMed  PubMed Central  Google Scholar 

  107. Hundorfean G, Pereira SP, Karstensen JG, Vilmann P, Saftoiu A. Modern endoscopic imaging in diagnosis and surveillance of inflammatory bowel disease patients. Gastroenterol Res Pract. 2018;2018:5738068.

    PubMed  PubMed Central  Google Scholar 

  108. Bopanna S, Roy M, Das P, Dattagupta S, Sreenivas V, Mouli VP, Kedia S, Dhingra R, Pradhan R, Kumar NS, Yadav DP. Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer. Intest Res. 2016;14(3):264.

    PubMed  PubMed Central  Google Scholar 

  109. Johnson DH, Khanna S, Smyrk TC, Loftus EV Jr, Anderson KS, Mahoney DW, Ahlquist DA, Kisiel JB. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn’s colitis. Aliment Pharmacol Ther. 2014;39(12):1408–17.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, Ha CY, Bayless TM, Giardiello F, Hart J, Montgomery E. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016;84(1):87–95.

    PubMed  Google Scholar 

  111. Tominaga K, Kamimura K, Takahashi K, Yokoyama J, Yamagiwa S, Terai S. Diversion colitis and pouchitis: a mini-review. World J Gastroenterol. 2018;24(16):1734.

    PubMed  PubMed Central  Google Scholar 

  112. Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, Makharia G, Ahuja V. Differentiating Crohn’s disease from intestinal tuberculosis. World J Gastroenterol. 2019;25(4):418.

    PubMed  PubMed Central  Google Scholar 

  113. Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn’s disease. Hepato-Gastroenterology. 1990;37:18–31.

    CAS  PubMed  Google Scholar 

  114. Makharia GK, Srivastava S, Das P, Goswami P, Singh U, Tripathi M, Deo V, Aggarwal A, Tiwari RP, Sreenivas V, Gupta SD. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105(3):642–51.

    PubMed  Google Scholar 

  115. Warren BF. Classic pathology of ulcerative and Crohn’s colitis. J Clin Gastroenterol. 2004;38:S33–5.

    PubMed  Google Scholar 

  116. Lockhart-Mummery HE, Morson BC. Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut. 1960;1(2):87–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  117. Ouyang Q, Tandon R, Goh KL, Pan G-Z, Fock KM, Fiocchi C, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006;21(12):1772–82.

    PubMed  Google Scholar 

  118. Price AB, Morson BC. Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis. Hum Pathol. 1975;6(1):7–29.

    CAS  PubMed  Google Scholar 

  119. Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn’s disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79(9):955–8.

    CAS  PubMed  Google Scholar 

  120. Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Patra S, Mathan VI, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis. Gut. 1999;45(4):537–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  121. Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol. 2003;16(4):347–58.

    PubMed  Google Scholar 

  122. Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC. Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease. Gut. 2005;54(2):215–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  123. Rotterdam H, Korelitz BI, Sommers SC. Microgranulomas in grossly normal rectal mucosa in Crohn’s disease. Am J Clin Pathol. 1977;67(6):550–4.

    CAS  PubMed  Google Scholar 

  124. Das P, Rampal R, Udinia S, Kumar T, Pilli S, Wari N, Ahmed IK, Kedia S, Gupta SD, Kumar D, Ahuja V. Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn’s disease, in comparison to intestinal tuberculosis. Intest Res. 2018;16(3):426.

    PubMed  PubMed Central  Google Scholar 

  125. Novak G, Parker CE, Pai RK, MacDonald JK, Feagan BG, Sandborn WJ, D’Haens G, Jairath V, Khanna R. Histologic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database Syst Rev. 2017;7:CD012351.

    PubMed  Google Scholar 

  126. Baert F, Moortgat L, Van Assche G, et al. Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology. 2010;138(2):463–468. [PubMed] [Google Scholar]; Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis. 2009;15(9):1295–301.

    Google Scholar 

  127. Cheifetz AS. Management of active Crohn disease. JAMA. 2013;309(20):2150–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  128. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon. Inflamm Bowel Dis. 2009;15(4):630–8.

    PubMed  Google Scholar 

  129. Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH. Adenocarcinoma of the small intestine in Crohn’s disease. Surg Gynecol Obstet. 1991;173:343–9.

    CAS  PubMed  Google Scholar 

  130. Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, Lémann M, Bonaz B, Denet C, Marteau P, et al. Small bowel adenocarcinoma in patients with Crohn’s disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828–32.

    PubMed  Google Scholar 

  131. Michelassi F, Testa G, Pomidor WJ, Lashner BA, Block GE. Adenocarcinoma complicating Crohn’s disease. Dis Colon Rectum. 1993;36:654–61.

    CAS  PubMed  Google Scholar 

  132. Cahill C, Gordon PH, Petrucci A, Boutros M. Small bowel adenocarcinoma and Crohn’s disease: any further ahead than 50 years ago? WorldJ Gastroenterol. 2014;20(33):11486–95.

    Google Scholar 

  133. Goetz M. Endoscopic surveillance in inflammatory bowel disease. Visc Med. 2018;34(1):66–71.

    PubMed  PubMed Central  Google Scholar 

  134. Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn’s disease. J Gastroenterol Hepatol. 2018;33(2):355–64.

    PubMed  Google Scholar 

  135. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6(1):8–15.

    CAS  PubMed  Google Scholar 

  136. Lazarev M, Huang C, Bitton A, et al. Relationship between proximal Crohn’s disease location and disease behaviour and surgery; a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013;108:106–12.

    CAS  PubMed  Google Scholar 

  137. Renault M, Goodier A, Subramony C, Hood B, Bishop P, Nowicki M. Age-related differences in granulomatous gastritis: a retrospective, clinicopathological analysis. J Clin Pathol. 2010;63(04):347–50.

    PubMed  Google Scholar 

  138. Goodhand J, Dawson R, Hefferon M, et al. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis. 2010;16(06):947–52.

    CAS  PubMed  Google Scholar 

  139. Wagtmans M, van Hogezand R, Griffoen G, Verspaget H, Lamers C. Crohn’s disease of the upper gastrointestinal tract. Neth J Med. 1997;50:S2–7.

    CAS  PubMed  Google Scholar 

  140. Miehsler W, Puspok A, Oberhuber G, Vogelsang H. Impact of different therapeutic regimens on the outcome of patients with Crohn’s disease of the upper gastrointestinal tract. Inflamm Bowel Dis. 2001;7:99–105.

    CAS  PubMed  Google Scholar 

  141. Pimentel AM, Rocha R, Santana GO. Crohn’s disease of esophagus, stomach and duodenum. World J Gastrointest Pharmacol Ther. 2019;10(2):35–49.

    PubMed  PubMed Central  Google Scholar 

  142. Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.

    PubMed  PubMed Central  Google Scholar 

  143. Feagans J, Victor D, Joshi V. Crohn disease of the esophagus: a review of the literature. South Med J. 2008;101:927–30.

    PubMed  Google Scholar 

  144. Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7:113–9.

    CAS  PubMed  Google Scholar 

  145. Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7:113–9.

    CAS  PubMed  Google Scholar 

  146. Mottet C, Juillerat P, Pittet V, Gonvers JJ, Michetti P, Vader JP, Felley C, Froehlich F. Upper gastrointestinal Crohn’s disease. Digestion. 2007;76:136–40.

    PubMed  Google Scholar 

  147. van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn’s disease: review of the clinicopathologic features and therapy. Inflamm Bowel Dis. 2001;7:328–37.

    PubMed  Google Scholar 

  148. Loftus EV Jr. Upper gastrointestinal tract Crohn’s disease. Clin Perspect Gastroenterol. 2002;5:188–91.

    Google Scholar 

  149. Oberhuber G, Puspok A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Potzi R, Stolte M, Wrba F. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterology. 1997;112:698–706.

    CAS  PubMed  Google Scholar 

  150. Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, Vago L, Porro GB. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol. 2000;95:705–11.

    CAS  PubMed  Google Scholar 

  151. Wagtmans MJ, van Hogezand RA, Griffioen G, Verspaget HW, Lamers CB. Crohn’s disease of the upper gastrointestinal tract. Neth J Med. 1997;50:S2–S7. Loftus EV, Jr Upper gastrointestinal tract Crohn’s disease. Clin Perspect Gastroenterol. 2002;5:188–91.

    Google Scholar 

  152. Yao K, Yao T, Iwashita A, Matsui T, Kamachi S. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn’s colitis from ulcerative colitis. Am J Gastroenterol. 2000;95:1967–73.

    CAS  PubMed  Google Scholar 

  153. Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology. 2006;48(2):116–32.

    CAS  PubMed  Google Scholar 

  154. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.

    PubMed  Google Scholar 

  155. Rinawi F, Assa A, Eliakim R, Mozer-Glassberg Y, Nachmias Friedler V, Niv Y, et al. The natural history of pediatric-onset IBD-unclassified and prediction of Crohn’s disease reclassification: a 27-year study. Scand J Gastroenterol. 2017;52(5):558–63.

    PubMed  Google Scholar 

  156. Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis. 2006;12:258–62.

    PubMed  Google Scholar 

  157. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum-is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11:88–98.

    PubMed  Google Scholar 

  158. Romano C, Famiani A, Gallizzi R, Comito D, Ferrau’ V, Rossi P. Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children. Pediatrics. 2008;122:e1278–81.

    PubMed  Google Scholar 

  159. Malaty HM, Mehta S, Abraham B, Garnett EA, Ferry GD. The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period. Clin Exp Gastroenterol. 2013;6:115–21.

    PubMed  PubMed Central  Google Scholar 

  160. Ruemmele FM, El Khoury MG, Talbotec C, Maurage C, Mougenot JF, Schmitz J, Goulet O. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603–9.

    PubMed  Google Scholar 

  161. Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 2015;169(11):1053–60.

    PubMed  PubMed Central  Google Scholar 

  162. Levine A, de Bie CI, Turner D, Cucchiara S, Sladek M, Murphy MS, Escher JC. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;19:370–7.

    PubMed  Google Scholar 

  163. Aloi M, D’Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S. Presenting features and disease course of pediatric ulcerative colitis. J Crohns Colitis. 2013;7:e509–15. PMID: 23583691. https://doi.org/10.1016/j.crohns.2013.03.007.

    Article  PubMed  Google Scholar 

  164. Kapoor A, Bhatia V, Sibal A. Pediatric inflammatory bowel disease. Indian Pediatr. 2016;53(11):993–1002.

    PubMed  Google Scholar 

  165. Martland GT, Shepherd NA. Indeterminate colitis: definition, diagnosis, implications and a plea for nosological sanity. Histopathology. 2007;50:83–96.

    CAS  PubMed  Google Scholar 

  166. Sathiyasekaran M, Bavanandam S, Sankaranarayanan S, Mohan N, Geetha M, Wadhwa N, et al. A questionnaire survey of pediatric inflammatory bowel disease in India. Indian J Gastroenterol. 2014;33:543–9.

    PubMed  Google Scholar 

  167. Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3.

    PubMed  Google Scholar 

  168. Rigoli L, Alberto RC. Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review. World J Gastroenterol. 2014;20(30):10262–78.

    PubMed  PubMed Central  Google Scholar 

  169. Shah S, Thomas V, Mathan M, Chacko A, Chandy G, Ramakrishna BS, et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut. 1992;33(3):347–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  170. Pettengell KE, Larsen C, Garb M, Mayet FG, Simjee AE, Pirie D. Gastrointestinal tuberculosis in patients with pulmonary tuberculosis. Q J Med. 1990;74(275):303–8.

    CAS  PubMed  Google Scholar 

  171. LaSala PR, Chodosh A, Vecchio JA, Schned LM, Blaszyk H. Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol. 2005;39:891–3.

    PubMed  Google Scholar 

  172. Chetty R, Govender D. Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis. Nat Rev Gastroenterol Hepatol. 2012;9(4):209.

    CAS  PubMed  Google Scholar 

  173. Shepherd NA. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol. 1991;44(9):726–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  174. Brandt LJ, Feuerstadt P, Blaszka MC. Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol. 2010;105(10):2245–52.

    PubMed  Google Scholar 

  175. Lavu K, Minocha A. Mesenteric inflammatory veno-occlusive disorder: a rare entity mimicking inflammatory bowel disorder. Gastroenterology. 2003;125(1):236–9.

    PubMed  Google Scholar 

  176. Mulhall AM, Mahid SS, Petras RE, Galandiuk S. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum. 2009;52(6):1072–9.

    PubMed  Google Scholar 

  177. Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017;15:138–41.

    PubMed  PubMed Central  Google Scholar 

  178. Cheng L, Huang MF, Mei PF, Bo WH, Deng CS. The clinical, endoscopic and pathologic features of Crohn’s disease in the differentiation from intestinal tuberculosis. Zhonghua Nei Ke Za Zhi. 2013;52:940–4.

    PubMed  Google Scholar 

  179. Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol. 2009;104:1003–12.

    PubMed  Google Scholar 

  180. Huang X, Liao WD, Yu C, Tu Y, Pan XL, Chen YX, Lv NH, Zhu X. Differences in clinical features of Crohn’s disease and intestinal tuberculosis. World J Gastroenterol. 2015;21:3650–6.

    PubMed  PubMed Central  Google Scholar 

  181. Li X, Liu X, Zou Y, Ouyang C, Wu X, Zhou M, Chen L, Ye L, Lu F. Predictors of clinical and endoscopic findings in differentiating Crohn’s disease from intestinal tuberculosis. Dig Dis Sci. 2011;56:188–96.

    PubMed  Google Scholar 

  182. Kedia S, Sharma R, Nagi B, Mouli VP, Aananthakrishnan A, Dhingra R, Srivastava S, Kurrey L, Ahuja V. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–43.

    PubMed  Google Scholar 

  183. Yadav DP, Madhusudhan KS, Kedia S, Sharma R, Pratap Mouli V, Bopanna S, Dhingra R, Pradhan R, Goyal S, Sreenivas V, Vikram NK, Makharia G, Ahuja V. Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn’s disease and intestinal tuberculosis. J Gastroenterol Hepatol. 2017;32:420–6.

    CAS  PubMed  Google Scholar 

  184. Bae JH, Park SH, Ye BD, Kim SO, Cho YK, Youn EJ, Lee HS, Hwang SW, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK. Development and validation of a novel prediction model for differential diagnosis between Crohn’s disease and intestinal tuberculosis. Inflamm Bowel Dis. 2017;23:1614–23.

    PubMed  Google Scholar 

  185. Patel N, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Gupte P. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol. 2004;19:1240–6.

    PubMed  Google Scholar 

  186. Kumar S, Bopanna S, Kedia S, Mouli P, Dhingra R, Padhan R, Kohli M, Chaubey J, Sharma R, Das P, Dattagupta S, Makharia G, Sharma SK, Ahuja V. Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis. Intest Res. 2017;15:187–94.

    PubMed  PubMed Central  Google Scholar 

  187. Amarapurkar DN, Patel ND, Amarapurkar AD, Agal S, Baigal R, Gupte P. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn’s disease. J Assoc Physicians India. 2004;52:863–7.

    CAS  PubMed  Google Scholar 

  188. Fei BY, Lv HX, Zheng WH. Fluorescent quantitative PCR of Mycobacterium tuberculosis for differentiating intestinal tuberculosis from Crohn’s disease. Braz J Med Biol Res. 2014;47:166–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  189. Ghoshal UC, Ghoshal U, Singh H, Tiwari S. Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn’s disease and intestinal tuberculosis in India. J Postgrad Med. 2007;53:166–70.

    CAS  PubMed  Google Scholar 

  190. Kedia S, Madhusudhan KS, Sharma R, Bopanna S, Yadav DP, Goyal S, Jain S, Das P, Dattagupta S, Makharia G, Ahuja V. Combination of increased visceral fat and long segment involvement: development and validation of an updated imaging marker for differentiating Crohn’s disease from intestinal tuberculosis. J Gastroenterol Hepatol. 2018;33:1234–41.

    PubMed  Google Scholar 

  191. Ye Z, Lin Y, Cao Q, He Y, Xue L. Granulomas as the most useful histopathological feature in distinguishing between Crohn’s disease and intestinal tuberculosis in endoscopic biopsy specimens. Medicine. 2015;94(49):e2157.

    PubMed  PubMed Central  Google Scholar 

  192. Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Mouli VP, Dhingra R, Makharia G, Ahuja V. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. Intest Res. 2018;16(4):588.

    PubMed  PubMed Central  Google Scholar 

  193. Di Altobrando A, Tartari F, Filippini A, D’Antuono A, Patrizi A, Filippi F, Sechi A, Cuicchi D, Salfi NC, Gaspari V. Lymphogranuloma venereum proctitis mimicking inflammatory bowel diseases in 11 patients: a 4-year single-center experience. Crohn’s & Colitis 360. 2019;1(1):otz004.

    Google Scholar 

  194. Boţianu AM, Boţianu P. A case of yersinia enterocolitica diverticulitis mimicking inflammatory bowel disease: the importance of differential diagnosis. Acta Medica Transilvanica. 2015;20(1).

    Google Scholar 

  195. Moore D, Dias F, Esberard E, Mugayar J, Costa M, Pestana S, Boechat JL, Rabelo R, Seba A. Common variable immunodeficiency misdiagnosed as Crohn Disease. World Allergy Organ J. 2015;8(1):A267–8.

    PubMed Central  Google Scholar 

  196. Armbruster S, Moncur J, Veerappan G. CVID: a masquerader of Crohn’s disease: P-125. Inflamm Bowel Dis. 2011;17(Suppl_2):S51.

    Google Scholar 

  197. Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17(1):251–9.

    PubMed  Google Scholar 

  198. Shivashankar R, Lichtenstein GR. Mimics of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(11):2315–21.

    PubMed  Google Scholar 

  199. Herrera AF, Soriano G, Bellizzi AM, et al. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365:815–24.

    CAS  PubMed  Google Scholar 

  200. Gupta NK, Masia R. Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract. Am J Surg Pathol. 2013;37(7):1109.

    PubMed  PubMed Central  Google Scholar 

  201. Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, Jung J, Michaud M, Walker BJ, Young S, Earl AM. Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369:517.

    CAS  PubMed  PubMed Central  Google Scholar 

  202. Zhu Z. Gastrointestinal manifestations of immunodeficiency. In: Greenberger NJ, Blumberg RS, Burakoff R, editors. Current diagnosis & treatment: gastroenterology, hepatology, & endoscopy. 3e ed. USA: McGraw Hill Education; 2016.

    Google Scholar 

  203. Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205.e1–8.

    PubMed  Google Scholar 

  204. Agarwal S, Cunningham-Rundles C. Gastrointestinal manifestations and complications of primary immunodeficiency disorders. Immunol Allergy Clin N Am. 2019;39:81–94.

    Google Scholar 

  205. Washington K, Shi C. In: Odze RD, Goldblum JR, editors. Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia: Saunders/Elsevier; 2015.

    Google Scholar 

  206. Heyworth MF, Carlson JR, Ermak TH. Clearance of Giardia muris infection requires helper/inducer T lymphocytes. J Exp Med. 1987;165:1743–8.

    CAS  PubMed  Google Scholar 

  207. Meini A, Pillan NM, Villanacci V, Monafo V, Ugazio AG, Plebani A. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann Allergy Asthma Immunol. 1996;77:333–6.

    CAS  PubMed  Google Scholar 

  208. Yazdani R, Azizi G, Abolhassani H, et al. Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand J Immunol. 2017;85:3–12.

    CAS  PubMed  Google Scholar 

  209. Haimila K, Einarsdottir E, de Kauwe A, Koskinen LL, Pan-Hammarström Q, et al. The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency. Genes Immun. 2009;10:151–61.

    CAS  PubMed  Google Scholar 

  210. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72:279–90.

    CAS  PubMed  Google Scholar 

  211. Väliaho J, Faisal I, Ortutay C, Smith CI, Vihinen M. Characterization of all possible single-nucleotide change caused amino acid substitutions in the kinase domain of Bruton tyrosine kinase. Hum Mutat. 2015;36:638–47.

    PubMed  Google Scholar 

  212. Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, et al. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37:287–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  213. Pac M, Bernatowska EA, Kierkus J, et al. Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center. Arch Med Sci. 2017;13:412–7.

    CAS  PubMed  Google Scholar 

  214. van der Meer JW, Weening RS, Schellekens PT, et al. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet. 1993;341:1439–40.

    PubMed  Google Scholar 

  215. Staines Boone AT, Torres Martinez MG, Lopez Herrera G, et al. Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature. J Clin Immunol. 2014;34:134–7.

    CAS  PubMed  Google Scholar 

  216. Lavilla P, Gil A, Rodríguez MC, Dupla ML, Pintado V, Fontán G. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer. 1993;72:1528–31.

    CAS  PubMed  Google Scholar 

  217. Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol. 2010;149:167–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  218. Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, et al. Hyper IgM Syndrome: a report from the USIDNET registry. J Clin Immunol. 2016;36:490–501.

    CAS  PubMed  PubMed Central  Google Scholar 

  219. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:38–59.

    PubMed  Google Scholar 

  220. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  221. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800–12.

    PubMed  Google Scholar 

  222. Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  223. Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105:2262–75.

    CAS  PubMed  Google Scholar 

  224. Gathmann B, Mahlaoui N, CEREDIH, Gérard L, Oksenhendler E, et al. and European Society for Immunodeficiencies Registry Working Party. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.

    Google Scholar 

  225. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieber-man P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987;7:294–9.

    CAS  PubMed  Google Scholar 

  226. de Bruin NC, de Groot R, den Hollander JC, et al. Small-cell undifferentiated (neuroendocrine) carcinoma of the cecum in a child with common variable immunodeficiency. Am J Pediatr Hematol Oncol. 1993;15:258–61.

    PubMed  Google Scholar 

  227. Adachi Y, Mori M, Kido A, et al. Multiple colorectal neoplasms in a young adult with hypogammaglobulinemia: report of a case. Dis Colon Rectum. 1992;35:197–200.

    CAS  PubMed  Google Scholar 

  228. Cossu F. Genetics of SCID. Ital J Pediatr. 2010;36:76.

    PubMed  PubMed Central  Google Scholar 

  229. Snover DC, Filipovich AH, Ramsay NK, et al. Graft-versus-host-disease-like histopathological findings in pre-bone-marrow transplantation biopsies of patients with severe T cell deficiency. Transplantation. 1985;39:95–7.

    CAS  PubMed  Google Scholar 

  230. Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Color Dis. 2006;8:637–44.

    CAS  Google Scholar 

  231. Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–24.

    CAS  PubMed  Google Scholar 

  232. Panarelli NC, Yantiss RK. Inflammatory and infectious manifestations of immunodeficiency in the gastrointestinal tract. Mod Pathol. 2018;31:844–61.

    PubMed  Google Scholar 

  233. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease: a bench-to-bedside update. Blood. 2014;124:363–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  234. Shulman HM, Cardona DM, Greenson JK, et al. NIH Consensus development project on criteria for clinical trials in chronic graft- versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015;21:589–603.

    PubMed  PubMed Central  Google Scholar 

  235. Xue Y, Farris AB, Quigley B, Krasinskas A. The impact of new technologic and molecular advances in the daily practice of gastrointestinal and hepatobiliary pathology. Arch Pathol Lab Med. 2017;141:517–27.

    CAS  PubMed  Google Scholar 

  236. Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol. 1999;23(10):1241–7.

    CAS  PubMed  Google Scholar 

  237. Swanson BJ, Limketkai BN, Liu TC, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37(11):1686–93.

    PubMed  Google Scholar 

  238. Iacobuzio-Donahue CA, Lee EL, Abraham SC, Yardley JH, Wu TT. Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol. 2001;25(8):1067–73.

    CAS  PubMed  Google Scholar 

  239. Daniels JA, Gibson MK, Xu L, et al. Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect. Am J Surg Pathol. 2008;32(3):473–7.

    PubMed  Google Scholar 

  240. De Petris G, Gatius Caldero S, Chen L, et al. Histopathological changes in the gastrointestinal tract due to drugs: an update for the surgical pathologist (part I of II). Int J Surg Pathol. 2014;22(2):120–8.

    PubMed  Google Scholar 

  241. Higuchi K, Umegaki E, Watanabe T, et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol. 2009;44(9):879–88.

    PubMed  Google Scholar 

  242. McCarthy AJ, Lauwers GY, Sheahan K. Iatrogenic pathology of the intestines. Histopathology. 2015;66(1):15–28.

    Google Scholar 

  243. Star KV, Ho VT, Wang HH, Odze RD. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol. 2013;37(9):1319–28.

    PubMed  Google Scholar 

  244. Lee S, de Boer WB, Subramaniam K, Kumarasinghe MP. Pointers and pitfalls of mycophenolate-associated colitis. J Clin Pathol. 2013;66(1):8–11.

    PubMed  Google Scholar 

  245. Dalle IJ, Maes BD, Geboes KP, Lemahieu W, Geboes K. Crohn’s-like changes in the colon due to mycophenolate? Color Dis. 2005;7(1):27–34.

    CAS  Google Scholar 

  246. Liapis G, Boletis J, Skalioti C, et al. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology. 2013;63(5):649–58.

    PubMed  Google Scholar 

  247. Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol. 2006;24(15):2283–9.

    CAS  PubMed  Google Scholar 

  248. Oble DA, Mino-Kenudson M, Goldsmith J, et al. Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis. Am J Surg Pathol. 2008;32(8):1130–7.

    PubMed  Google Scholar 

  249. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004;164(10):1054–62.

    PubMed  Google Scholar 

  250. Clair DG, Beach JM. Mesenteric Ischemia. N Engl J Med. 2016;374:959–68.

    CAS  PubMed  Google Scholar 

  251. Rosenblum JD, Boyle CM, Schwartz LB. The mesenteric circulation. Anatomy and physiology. Surg Clin North Am. 1997;77:289–306.

    CAS  PubMed  Google Scholar 

  252. Phillips B. Surgical cases. London Medical Gazette. 1839;23:514–7.

    Google Scholar 

  253. Case records of the Massachusetts General Hospital 1974. Case 36. N Engl J Med. 1974(291):569–75.

    Google Scholar 

  254. Sami SS, Al-Araji SA, Ragunath K. Review article: gastrointestinal angiodysplasia – pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2014;39:15–34.

    CAS  PubMed  Google Scholar 

  255. Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2008;22(2):313–28.

    PubMed  Google Scholar 

  256. Alghamdi T. Angiodysplasia in terminal ileum: case report and review of literature. Int J Surg Case Rep. 2020;66:165–8.

    PubMed  Google Scholar 

  257. Yoon W, Jeong YY, Shin SS, et al. Acute massive gastrointestinal bleeding: detection and localization with arterial phase multi–detector row helical CT. Radiology. 2006;239(1):160–7.

    PubMed  Google Scholar 

  258. Raju GS, Gerson L, Das A, Lewis B, American Gastroenterological Association. American Gastroenterological Association (AGA) institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133:1697–717.

    PubMed  Google Scholar 

  259. Wetwittayakhlang P, Wonglhow J, Netinatsunton N, et al. Re-bleeding and its predictors after capsule endoscopy in patients with obscure gastrointestinal bleeding in long-term follow-up. BMC Gastroenterol. 2019;19:216.

    PubMed  PubMed Central  Google Scholar 

  260. Boley S, et al. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology. 1977;72(4 Pt 1):650–60.

    CAS  PubMed  Google Scholar 

  261. https://emedicine.medscape.com/article/170719-overview.

  262. Siddique K, Ali Q, Mirza S, Malik AZ. Massive lower gastrointestinal hemorrhage in a patient with colonic angiodysplasia. Int J Surg. 2009;20.

    Google Scholar 

  263. Theis SR, Turner SD. Heyde Syndrome. [Updated 2020 July 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551625.

  264. Kaaroud H, Fatma LB, Beji S, Boubaker K, Hedri H, Hamida FB, El Younsi F, Abdallah TB, Maiz HB, Kheder A. Gastrointestinal angiodysplasia in chronic renal failure. Saudi J Kidney Dis Transpl. 2008;19(5):809–12.

    CAS  PubMed  Google Scholar 

  265. Thelmo WL, Vetrano JA, Wibowo A, DiMaio TM, Cruz-Vetrano WP, Kim DS. Angiodysplasia of colon revisited: pathologic demonstration without the use of intravascular injection technique. Hum Pathol. 1992;23(1):37–40.

    CAS  PubMed  Google Scholar 

  266. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol. 1993;88:807–18.

    CAS  PubMed  Google Scholar 

  267. Kido M, Nakamura K, Kuwahara T, et al. Arteriovenous malformation that caused prolapse of the colon and was treated surgically in an infant: a case report. Surg Case Rep. 2020;6:67.

    PubMed  PubMed Central  Google Scholar 

  268. Moore JO, Thompson NW, Appelman HO, Foley O. Arteriovenous malformations of the gastrointestinal tract. Arch Surg. 1976;111:381–8.

    CAS  PubMed  Google Scholar 

  269. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30(8):849–53.

    PubMed  Google Scholar 

  270. Lee HH, Kwon HM, Gil S, et al. Endoscopic resection of asymptomatic, colonic, polypoid arteriovenous malformations: two case reports and a literature review. Saudi J Gastroenterol. 2017;23(1):67–70.

    PubMed  PubMed Central  Google Scholar 

  271. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002;19:140–8.

    CAS  PubMed  Google Scholar 

  272. Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D. Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): a systematic review of the literature. Dig Dis Sci. 2017;62(10):2623–30.

    PubMed  PubMed Central  Google Scholar 

  273. Tortora A, Riccioni ME, Gaetani E, et al. Rendu-Osler-Weber disease: a gastroenterologist’s perspective. Orphanet J Rare Dis. 2019;14:130.

    PubMed  PubMed Central  Google Scholar 

  274. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91(1):66–7.

    CAS  PubMed  Google Scholar 

  275. Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med. 2014;5:191–206.

    PubMed  PubMed Central  Google Scholar 

  276. Proctor DD, Henderson KJ, Dziura JD, Longacre AV, White RI. Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia. J Clin Gastroenterol. 2005;39:115–9.

    PubMed  Google Scholar 

  277. Baskerville PA, Ackroyd JS, Browse NL. The etiology of the Klippel-Trenaunay syndrome. Ann Surg. 1985;202(5):624–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  278. Kido M, Nakamura K, Kuwahara T, et al. Arteriovenous malformation that caused prolapse of the colon and was treated surgically in an infant: a case report. Surg Case Rep. 2020;6:67.

    PubMed  PubMed Central  Google Scholar 

  279. Sharma D, Lamba S, Pandita A, Shastri S. Klippel-trénaunay syndrome - a very rare and interesting syndrome. Clin Med Insights Circ Respir Pulm Med. 2015;9:1–4.

    PubMed  PubMed Central  Google Scholar 

  280. Sepulveda A, Soriano H, Espino A. Gastrointestinal tract involvement in Klippel-Trénaunay syndrome. Lancet Gastroenterol Hepatol. 2018;3(7):518.

    PubMed  Google Scholar 

  281. Jeong SH, Joo D, Lim TJ, Lee YJ. Newly diagnosed Klippel-Trenaunay Syndrome presenting with rectal polyposis in a male pediatric patient: a case report. Pediatr Gastroenterol Hepatol Nutr. 2020;23(1):115–20.

    PubMed  PubMed Central  Google Scholar 

  282. Vahidnezhad H, Youssefian L, Uitto J. Klippel–Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol. 2016;25:17–9.

    CAS  PubMed  Google Scholar 

  283. Timur AA, Driscoll DJ, Wang Q. Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci. 2005;62(13):1434–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  284. Dieulafoy G. Exulceratio simplex: leçons 1–3. In: Dieulafoy G, editor. Clinique Médicale de l’Hotel Dieu de Paris. Paris, France: Masson et Cie; 1898. p. 1–38.

    Google Scholar 

  285. Holley CJ. History of hemorrhoidal surgery. South Med J. 1946;39:536–41.

    CAS  PubMed  Google Scholar 

  286. Loder PB, Kamm MA, Nicholls RJ, Phillips RK. Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg. 1994;81(7):946–54.

    CAS  PubMed  Google Scholar 

  287. Goligher JC. Surgery of the anus, rectum and colon. 4th ed. London: Ballierè Tindal; 1980.

    Google Scholar 

  288. Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroenterol. 2019;32(3):264–72.

    PubMed  PubMed Central  Google Scholar 

  289. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–6.

    PubMed  PubMed Central  Google Scholar 

Download references

Disclaimer

The authors agree to the fact that all biopsy procedures and surgical resections were performed after taking informed consent from respective patients as per the individual Institutional policies, which also includes consent for publishing the unidentified clinical images for publication or research purposes. The authors also declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, Christian Medical College, Vellore, Tamil Nadu, India

    Tanush Vig & Anna Pulimood

  2. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  3. Department of Pathology, Govind Ballabh Pant Institute of Postgraduate Medical Education & Research, New Delhi, India

    Puja Sakhuja

  4. Department of Pathology, Lady Hardinge Medical College, New Delhi, India

    Kavita Gaur

  5. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

Authors
  1. Tanush Vig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prasenjit Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Puja Sakhuja
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kavita Gaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kaushik Majumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Pulimood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prasenjit Das .

Editor information

Editors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

  2. Department of Pathology, Al Sabah Hospital, Kuwait City, Kuwait

    Kaushik Majumdar

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Siddhartha Datta Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vig, T., Das, P., Sakhuja, P., Gaur, K., Majumdar, K., Pulimood, A. (2022). Pathology of Inflammatory Bowel Diseases and Its Mimickers, Immunodeficiency and Vascular Gastrointestinal Lesions, and Drug-Induced Bowel Pathologies. In: Das, P., Majumdar, K., Datta Gupta, S. (eds) Surgical Pathology of the Gastrointestinal System. Springer, Singapore. https://doi.org/10.1007/978-981-16-6395-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6395-6_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6394-9

  • Online ISBN: 978-981-16-6395-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation